RecruitingNot ApplicableNCT06807294

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Sponsor

Dana-Farber Cancer Institute

Enrollment

21 participants

Start Date

Jan 16, 2026

Study Type

INTERVENTIONAL

Conditions

Chemotherapy-induced Peripheral Neuropathy (CIPN)Neuropathy Peripheral Neuropathy Due to Chemotherapy Peripheral Neuropathies

Summary

This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Tai Chi Program for people with chemotherapy-induced peripheral neuropathy (cipn), neuropathy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTai Chi Program

12-week virtual Tai Chi program with experienced Tai Chi instructor. Sessions will be conducted via the HIPPA-compliant teleconference platform, Zoom.

Locations(1)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06807294

Related Trials

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

NCT069592776 locations

Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects

NCT076975601 location

Neurologic Stem Cell Treatment Study

NCT027950523 locations

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

NCT067448161 location

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

NCT0714230418 locations